An interim analysis of an open-label extension study to examine the long-term safety and tolerability of pimavanserin in the treatment of Parkinson's disease psychosis
MOVEMENT DISORDERS(2010)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
MOVEMENT DISORDERS(2010)